| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $185.5M | -2.2% | -4.3% |
| Cost of Revenue | $172.9M | -0.6% | +3.6% |
| R&D Expense | $10.2M | +8.7% | +6.0% |
| SG&A Expense | $32.0M | +5.8% | +18.2% |
| Operating Income | -$61.3M | -2.9% | -46.3% |
| Pre-tax Income | -$82.4M | -1.3% | -43.7% |
| Income Tax | $1.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $125.3M | +17.1% | +8.1% |
| Accounts Receivable | $32.4M | -16.3% | +1.1% |
| Inventory | $9.1M | -24.8% | -59.4% |
| Current Assets | $248.3M | +6.3% | -8.5% |
| Total Assets | $973.0M | -3.3% | -6.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$147.9M | — | — |
| Capital Expenditures | $53.7M | — | — |
| Investing Cash Flow | $43.4M | — | — |
| Financing Cash Flow | $11.4M | — | — |
| Free Cash Flow | -$201.7M | — | — |
| +38.9% |
| +228.9% |
| Net Income | -$83.7M | -1.7% | -45.0% |
| EPS (Basic) | -$0.12 | +0.0% | -50.0% |
| EPS (Diluted) | -$0.12 | +0.0% | -50.0% |
| $887.5M |
| -1.6% |
| -0.1% |
| Long-term Debt | $766.5M | -0.5% | +28.4% |
| Total Liabilities | $1.35B | -0.4% | +16.4% |
| Stockholders' Equity | -$374.5M | -7.7% | -218.3% |